Jing Rong Cui
Fundador en Blossomhill Therapeutics, Inc. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Yi Shan Li | M | 59 |
Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | 11 años |
Carl Gordon | M | 59 |
Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | 4 años |
Scott Lipman | M | - | 4 años | |
Bihua Chen | F | 55 |
Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | - |
George Lee | M | 73 |
Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | - |
Gavin Hirst | M | - | 4 años | |
Naresh K. Nayyar | M | - | 6 años | |
Miriam Cruz | F | - | 6 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Athena Countouriotis | M | 52 | - | |
Brian Baker | M | 57 | 4 años | |
Garry Nicholson | M | 69 | 2 años | |
Clarence Machado | M | 60 | 3 años | |
Jacob Chacko | M | 45 | 3 años | |
Sheila Gujrathi | M | 53 | 4 años | |
Carol Gallagher | M | 59 | 3 años | |
Simeon George | M | 47 | 5 años | |
Hong Bo Lu | M | 53 | 2 años | |
Annette C. North | F | 58 | 3 años | |
Robert J. Adelman | M | 61 | - | |
Lewis J. Shuster | M | 68 | - | |
Dana Hu-Lowe | M | - | 2 años | |
Brett Zbar | M | 51 | 1 años | |
Mohammad Hirmand | M | 54 | 3 años | |
Yuelie Lu | M | 66 | 1 años | |
Kenneth Fong | M | - | - | |
Siegfried Reich | M | 64 | 2 años | |
Homa Yeganegi | F | - | - | |
Jakob Loven | M | 46 | 1 años | |
Yi Larson | F | 44 | 2 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 29 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Jing Rong Cui
- Red Personal